Facebook
Twitter
LinkedIn
ForwardMayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 - Livestream (virtual)
This course offers Live (in-person) and Livestream (virtual) attendance options
Division Chairs: Vesna D. Garovic. M.D., Ph.D., Minnesota, Harini Chakkera, M.D., M.P.H., Arizona, LaTonya Hickson M.D., Florida, and Tambi Jarmi, M.D., Florida
Course Directors: Ladan Zand, M.D., Ziad Zoghby, M.D., M.B.A., Hatem Amer, M.D., Jacque R. Wanek, APRN, C.N.P., M.S.N., Erin M. Dahlen, R.N., Becky M. Ness, P.A.-C. and Erin F. Barreto, Pharm.D., R.Ph.
Course Co-Directors: Musab S. Hommos, M.B.B.S., Hani M. Wadei, M.D., and Ivan E. Porter, II, M.D.
February 16 - 18, 2024 - Internet Live Activity - Coronado, California
The Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 is a two-and-a-half-day symposium designed to update participants on a range of nephrology topics relevant to current medical practice. Through a combination of lectures, literature review, and case-based presentations, this symposium delivers up-to-date and cutting-edge information that can be directly integrated into clinical practice.
Course Highlights:
- Practical case-based discussions with a panel of experts in the field to increase the participants’ involvement in this course by using practical cases from the real world
- Onconephrology session
- Dedicated glomerulonephritis (GN) session day with internationally known experts in the field with state-of-the-art lectures
- Describe the role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in specific patient population including those with diabetic nephropathy, chronic kidney disease, glomerulonephritis and post kidney transplantation
- Genetic testing in chronic kidney disease patients session
- Networking opportunities
- Abstract session
Abstract Session - Deadline January 5, 2024
As part of the Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024, a Poster Session for presentation of original research and challenging cases dedicated to the fields of Nephrology, Hypertension, and Transplant will be held at this meeting. Accepted abstract recipients will be chosen from all abstracts received by the submission deadline. Registration is required for all poster presenters. For further information email FLA CME Abstracts.
Target Audience
This course is intended for members of the nephrology community and will be of interest to nephrologists, nephrology trainees, nurse practitioners, physician assistants, internists, primary care physicians and other specialists who participate in the care of patients with kidney disorders and kidney and/or pancreas transplants.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Outline emerging therapies in lupus nephritis and IgA nephropathy.
- Identify innovative peritoneal dialysis approaches in the dialysis population.
- Recognize new biomarkers in diagnosing acute kidney injury.
- Examine the value of artificial intelligence in acute kidney injury.
- Describe how new cancer therapies including immunotherapies and CAR T-cell therapies can cause kidney injury.
- Discuss the role of emerging therapies in chronic kidney disease management.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 February 16-18, 2024
Coronado Island Marriott Resort & Spa Coronado, CA
All Presentation Times in Pacific Time | ||
Friday, February 16th, 2024 | ||
6:45 am | Registration and Exhibits | |
7:00 am | Breakfast and Non-CME Product Theater | |
7:50 am | Welcome Introductions Ladan Zand, M.D., Mayo Clinic Rochester | |
| Glomerulonephritis – Session 1 Moderator: Ladan Zand, M.D., Mayo Clinic Rochester | |
8:00 am | Approach to treating patients with lupus nephritis – what do the new trials tell us? Liz Lightstone, M.D., Ph.D., Imperial College London, UK | |
8:25 am | What should I know about systemic lupus erythematosus as a nephrologist? – a rheumatologist point of view. Ali Duarte Garcia, M.D., Mayo Clinic Rochester | |
8:50 am | Q and A | |
9:00am | Case-based discussion on workup and management of patients with lupus nephritis. Liz Lightstone, M.D., Ph.D., Imperial College London, UK and Ali Duarte Garcia, Mayo Clinic Rochester | |
10:00 am | Coffee Break and Exhibits | |
| Glomerulonephritis – Session 2 Moderator: Andrea G. Kattah, M.D., Mayo Clinic Rochester | |
10:20 am | How to treat severe ANCA-associate vasculitis? The role of Avacopan and PLEX in 2024. Ulrich Specks, M.D., Mayo Clinic Rochester | |
10:45 am | Q and A | |
10:50 am | Diagnostic challenges in patients with FSGS. Fernando Fervenza, M.D., Ph.D. Mayo Clinic Rochester | |
11:15 am | State of the art management of patients with primary podocytopathy. Richard Glassock, M.D., FASN, UCLA | |
12:00 pm | Q and A | |
12:10 pm | Lunch and Non-CME Product Theater | |
| Glomerulonephritis – Session 3 Moderator: Mireille El Ters, M.D., Mayo Clinic Rochester | *Session will not be livestreamed* ALLIED HEALTH – CKD – Session 1 Moderator: Jason N. Barreto, Pharm.D., R.Ph., Mayo Clinic Rochester |
1:20 pm | Mass spectrometry for glomerular diseases: Part 1 - Diagnosis (amyloidosis) Part 2 - Discovery (membranous nephropathy) Part 3 - Pathways (complement) Sanjeev Sethi, M.D., Ph.D., Mayo Clinic Rochester | Approach to patients with resistant hypertension. Musab S. Hommos, M.B.B.S., Mayo Clinic Arizona |
1:45 pm | Management of bone mineral disorders in CKD. Michael A. Mao, M.D., Mayo Clinic Florida | |
2:10 pm | Membranous nephropathy – treatment updates. Fernando Fervenza, M.D., Ph.D. Mayo Clinic Rochester | Electrolyte disorders (hyperkalemia and acidosis) in CKD. Mira T. Keddis, M.D., Mayo Clinic Arizona |
2:35 pm | Q and A | Q and A |
2:45 pm | Coffee Break and Exhibits | |
| Glomerulonephritis – Session 4 Moderators: Evamaria Anvari, M.D., Mayo Clinic Arizona | *Session will not be livestreamed* ALLIED HEALTH - Transplant – Session 2 Moderator: Andrew J. Bentall, M.B., Ch.B., M.D., Mayo Clinic Rochester |
3:05 pm | How to approach treating a patient with IgA nephropathy? Ladan Zand, M.D. Mayo Clinic Rochester | What should I do for a prior kidney donor? Naim S. Issa, M.D., Mayo Clinic Rochester |
3:30 pm | Q and A | Q and A |
3:35 pm | Case-based discussion on management of patients with IgA nephropathy. Richard Glassock, M.D., FASN, UCLA and Fernando Fervenza, M.D., Ph.D., Mayo Clinic Rochester | Immunosuppression management post transplantations. Pooja Budhiraja, M.B.B.S., Mayo Clinic Arizona |
4:00 pm | Q and A | |
4:05 pm | Break | |
4:25 pm | How to manage GN patients during pregnancy? Case-based discussion. Vesna D. Garovic, M.D., Ph.D., Mayo Clinic Rochester, Andrea G. Kattah, M.D., Mayo Clinic Rochester and Liz Lightstone, M.D., Ph.D., Imperial College London, UK | |
5:25 pm | Welcome Reception, Abstract Session, and Networking | |
6:45 pm | Adjourn | |
| ||
Saturday, February 17th, 2024 | ||
6:45 am | Registration and Exhibits | |
7:00 am | Breakfast and Non-CME Product Theater | |
7:50 am | Introductions Hani M. Wadei, M.D. Mayo Clinic Florida | |
7:55 am | Stem cell transplantation in nephrology – is this the future? LaTonya J. Hickson, M.D., M.D. Mayo Clinic Florida | |
8:20 am | Q&A | |
8:25 am | Break | |
| Onco-nephrology – Session 1 Moderators: Sandra M. Herrmann, M.D., Mayo Clinic Rochester | *Session will not be livestreamed* Transplantation – Session 1 Moderators: Hatem Amer, M.D., Mayo Clinic Rochester |
8:30 am | Monoclonal gammopathy of renal significance– approach to diagnosis. Ladan Zand, M.D., Mayo Clinic Rochester | Overcoming disparities in Transplantation. Girish K. Mour, M.B.B.S., M.D., Mayo Clinic Arizona |
8:55 am | Monoclonal gammopathy of renal significance – approach to treatment. Nelson Leung, M.D., Mayo Clinic Rochester | Role of genetic testing in kidney transplant candidates and their potential donors. Mireille El Ters, M.D., Mayo Clinic Rochester |
9:20 am | Management of myeloma cast nephropathy. Niloufar Yarandi, M.D., Mayo Clinic, Rochester | Causes of late allograft dysfunction. Andrew J. Bentall, M.B., Ch.B., M.D., Mayo Clinic Rochester |
9:45 am | Kidney injury post hematopoietic stem cell transplant. Leticia Rolon, M.D., Mayo Clinic Rochester | Management of transplant patients upon return to dialysis. Naim S. Issa, M.D., Mayo Clinic Rochester |
10:10 am | Q and A | Q and A |
10:25 am | Coffee Break and Exhibits | |
| Onco-nephrology – Session 2 Moderators: Nelson Leung, M.D., Mayo Clinic Rochester | *Session will not be livestreamed* Transplantation – Session 2 Moderators: Harini A. Chakkera, M.D., Mayo Clinic Arizona |
10:45 am | Nephrotoxicity associated with chemotherapy, immunotherapy, and CAR-T cells therapy. Sandra M. Herrmann, M.D., Mayo Clinic Rochester | Treg cell therapy in kidney transplantation. Nikolaos Skartsis, M.D., Ph.D., Mayo Clinic Rochester |
11:10 am | Anti-VEGF-induced hypertension - Mechanisms and treatment. Vesna Garovic, M.D., Ph.D., Mayo Clinic Rochester | Pitfalls of antibody testing. Andrew J. Bentall, M.B., Ch.B., M.D., Mayo Clinic Rochester |
11:35 am | Common electrolyte disorders in cancer patients. Hatim A. Hassan, M.D., Ph.D., Mayo Clinic Rochester | Recurrent FSGS post-transplantation. Hatem Amer, M.D., Mayo Clinic Rochester |
12:00 pm | Q and A | Q and A |
12:15 pm | Lunch and Non-CME Product Theater | |
| Acute kidney injury (AKI) Moderators: Mira T. Keddis, M.D., Mayo Clinic Arizona | *Session will not be livestreamed* ALLIED HEALTH – Dialysis – Session 3 Moderator: Jacque R. Wanek, APRN, C.N.P., M.S.N., Mayo Clinic Rochester |
1:30 pm | Acute kidney injury in liver disease. Hani M. Wadei, M.D. Mayo Clinic Florida | Coaching capacity in dialysis patients. Kasey R. Boehmer, Ph.D., M.P.H., Mayo Clinic Rochester |
1:50 pm | When and how to dialyze patients with acute kidney injury? Kambiz Kalantari, M.D., Mayo Clinic Rochester | How to choose the right dialysis modality for the right patient? Arvind K. Garg, M.B.B.S., M.D., FASN, Mayo Clinic Health System |
2:15 pm | How to use artificial intelligence in AKI? Jaleh Zand, Ph.D., Mayo Clinic Rochester | All you need to know when you get a call from the dialysis nurse regarding dialysis Access! Fawad Qureshi, M.D., Mayo Clinic Rochester |
2:40 pm | Diagnostic approach to AKI – biomarkers and beyond. Kianoush B. Kashani, M.D., M.S., Mayo Clinic Rochester | COVID-19 infection and vaccination in the dialysis population. Ziad Zoghby, M.D., M.B.A., Mayo Clinic Rochester |
3:05 pm | Q and A | Q and A |
3:25 pm | Coffee Break and Exhibits | |
| Hypertension Moderators: Musab S. Hommos, M.B.B.S., Mayo Clinic Arizona and Ziad Zoghby, M.D., M.B.A., Mayo Clinic Rochester | *Session will not be livestreamed* ALLIED HEALTH – AKI – Session 4 Moderator: Becky M. Ness, P.A.-C., Mayo Clinic Rochester |
3:45 pm | Aldosteronism and hypertension. Gary L. Schwartz, M.D., Mayo Clinic Rochester | Drug dosing and management in AKI. Erin F. Barreto, Pharm.D., R.Ph., Mayo Clinic Rochester |
4:10 pm | Blood pressure goals – does age matter? Sandra J. Taler, M.D., Mayo Clinic Rochester | Practical approach to patients with AKI, diagnosis and management. Fawad Qureshi, M.D., Mayo Clinic Rochester |
4:35 pm | Q and A | Q and A |
4:45 pm | Break | |
4:50 pm | Case based discussion on workup and management of difficult HTN cases. Gary L. Schwartz, M.D., Mayo Clinic Rochester and Sandra J. Taler, M.D., Mayo Clinic Rochester | |
5:50 pm | Adjourn |
|
| ||
Sunday, February 18th, 2024 | ||
6:45 am | Registration and Exhibits | |
7:00 am | Breakfast and Non-CME Product Theater | |
7:55 am | Introductions Harini A. Chakkera, M.D., Mayo Clinic Arizona | |
| Chronic Kidney Disease, and Dialysis Moderator: Kambiz Kalantari, M.D., Mayo Clinic Rochester | |
8:00 am | SGLT2-I – who should we target (special populations: DM, CKD, GN, and transplant)? Aleksandra Kukla, M.D., Mayo Clinic Rochester | |
8:25 am | How to slow CKD progression? – beyond RASS blockade and SGLT2-I. Michael A. Mao, M.D., Mayo Clinic Florida | |
8:50 am | Q and A | |
9:00am | What’s new in anemia management in CKD and dialysis? Andrea G. Kattah, M.D., Mayo Clinic Rochester | |
9:25 am | Peritoneal dialysis – thinking outside the cycler. Arvind K. Garg, M.B.B.S., M.D., FASN, Mayo Clinic Health System | |
9:50 am | What is the right access for your hemodialysis patient? Nabeel Aslam, M.D., Mayo Clinic Florida | |
10:15 am | Q and A | |
10:30 am | Coffee Break and Exhibits | |
| ADPKD and Genetic Kidney Diseases Moderator: Ziad Zoghby, M.D., M.B.A., Mayo Clinic Rochester | |
10:50 am | Imaging and biomarkers in ADPKD. Fouad T. Chebib, M.D., Mayo Clinic Florida | |
11:15 am | Treatment strategies in patients with ADPKD. Neera K. Dahl, M.D., Ph.D., Mayo Clinic Rochester | |
11:40 am | Genetic testing in CKD – when, how, and how far? Filippo Pinto e Vairo, M.D., Ph.D. Mayo Clinic Rochester | |
12:05 pm | Q and A | |
12:20 pm | Closing Remarks Ladan Zand, M.D., Mayo Clinic Rochester | |
12:30 pm | Adjourn | |
All travel and lodging expenses are the sole responsibility of the individual registrant.
Division Chairs
Vesna D. Garovic. M.D., Ph.D., Minnesota
Harini Chakkera, M.D., Arizona
LaTonya Hickson M.D., Florida
Tambi Jarmi, M.D., Florida
Course Directors
Ladan Zand, M.D., Minnesota
Ziad Zoghby, M.D., M.B.A., Minnesota
Hatem Amer, M.D., Minnesota
Jacque R. Wanek, APRN, C.N.P., M.S.N., Minnesota
Erin M. Dahlen, R.N.
Becky M. Ness, P.A.-C.
Erin F. Barreto, Pharm.D., R.Ph., Minnesota
Course Co-Directors
Musab S. Hommos, M.B.B.S., Arizona
Hani M. Wadei, M.D., Florida
Ivan E. Porter, II, M.D., Florida
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 19.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 19.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 19.00 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
UAN number: JA0000238-0000-24-005-L01-P
IPCE
This activity was planned by and for the healthcare team, and learners will receive 19.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College of Physicians and Surgeons of Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Day | Credits |
|---|---|
| Friday | 7.50 |
| Saturday | 7.50 |
| Sunday | 4.00 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 19.00 AAPA Category 1
- 19.00 ABIM
- 19.00 ACPE
- 19.00 AMA PRA Category 1 Credit™
- 19.00 ANCC
- 19.00 Attendance
The course brings together a diverse mix of nephrologists, nephrology trainees, nurse practitioners, physician assistants, internists, primary care physicians, pharmacist and other allied health professionals who participate in the care of patients with kidney disorders, and patients with a transplanted kidney or pancreas.
If you are interested in exhibiting at this course please email Karen Steele.
Price
ONLY General Session will be offered as Livestream - the Allied Health Track and Transplant Track will NOT be livestreamed.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.